Oppenheimer Asset Management Inc. Has $445,000 Stake in Maximus, Inc. (NYSE:MMS)

Oppenheimer Asset Management Inc. grew its holdings in Maximus, Inc. (NYSE:MMS) by 21.6% during the 2nd quarter, HoldingsChannel reports. The firm owned 5,198 shares of the health services provider’s stock after acquiring an additional 923 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Maximus were worth $445,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Wealth Enhancement Advisory Services LLC increased its position in Maximus by 4.5% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 3,179 shares of the health services provider’s stock worth $272,000 after buying an additional 136 shares during the period. Envestnet Portfolio Solutions Inc. increased its position in Maximus by 2.4% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 6,479 shares of the health services provider’s stock worth $544,000 after acquiring an additional 149 shares during the period. Verdence Capital Advisors LLC raised its stake in Maximus by 3.7% during the 1st quarter. Verdence Capital Advisors LLC now owns 4,730 shares of the health services provider’s stock valued at $397,000 after purchasing an additional 167 shares during the last quarter. Bridge City Capital LLC boosted its holdings in Maximus by 0.8% in the 1st quarter. Bridge City Capital LLC now owns 24,182 shares of the health services provider’s stock valued at $2,029,000 after purchasing an additional 188 shares during the period. Finally, WR Wealth Planners LLC grew its position in Maximus by 4.6% in the 2nd quarter. WR Wealth Planners LLC now owns 4,525 shares of the health services provider’s stock worth $388,000 after purchasing an additional 198 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Maximus Stock Performance

NYSE:MMS opened at $89.98 on Friday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.59 and a current ratio of 1.59. The firm’s 50-day moving average is $89.75 and its 200-day moving average is $86.10. Maximus, Inc. has a 52-week low of $72.39 and a 52-week high of $93.97. The company has a market cap of $5.47 billion, a price-to-earnings ratio of 23.62 and a beta of 0.76.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.74 EPS for the quarter, beating the consensus estimate of $1.47 by $0.27. Maximus had a return on equity of 20.91% and a net margin of 5.59%. The firm had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.29 billion. During the same quarter in the prior year, the firm posted $0.78 EPS. The company’s revenue for the quarter was up 10.6% on a year-over-year basis. Equities research analysts anticipate that Maximus, Inc. will post 6.12 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.33%. Maximus’s dividend payout ratio is currently 31.50%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.